Literature DB >> 22554711

Photodynamic therapy-mediated DC immunotherapy is highly effective for the inhibition of established solid tumors.

Nam-Chul Jung1, Hee Jung Kim, Mi-Sun Kang, Jun-Ho Lee, Jie-Young Song, Han Geuk Seo, Yong-Soo Bae, Dae-Seog Lim.   

Abstract

Dendritic cell (DC)-mediated immunotherapy has not been as effective as expected for most solid tumors. This study demonstrates immune responses against solid tumors mediated by DCs charged with photodynamic therapy (PDT)-induced tumor lysates, which contain the heat shock protein (HSP) 70. PDT tumor lysate-pulsed DC (PDT-DC) inhibited the growth of mammary EMT6 tumors to a greater extent than freeze/thawed tumor lysate-pulsed DC (FT-DC) or PDT tumor lysates. PDT-DC also showed significant anti-tumor effects against fully-established (i.e., late-stage) solid tumors. Taken together, these results suggest that PDT-DC vaccination is more effective than conventional DC therapy for the treatment of cancers.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22554711     DOI: 10.1016/j.canlet.2012.04.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

1.  Calreticulin is an effective immunologic adjuvant to tumor-associated antigens.

Authors:  Jun Wang; Zhi Peng Gao; Song Qin; Chang Bai Liu; Li Li Zou
Journal:  Exp Ther Med       Date:  2017-08-22       Impact factor: 2.447

2.  CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer.

Authors:  Yumin Xia; Gaurav K Gupta; Ana P Castano; Pawel Mroz; Pinar Avci; Michael R Hamblin
Journal:  J Biophotonics       Date:  2013-08-07       Impact factor: 3.207

3.  Photodynamic therapy-mediated cancer vaccination enhances stem-like phenotype and immune escape, which can be blocked by thrombospondin-1 signaling through CD47 receptor protein.

Authors:  Yuanhong Zheng; Fangyuan Zou; Jingjing Wang; Guifang Yin; Vanminh Le; Zhewei Fei; Jianwen Liu
Journal:  J Biol Chem       Date:  2015-02-19       Impact factor: 5.157

4.  Synergistic effect of methionine encephalin (MENK) combined with pidotimod(PTD) on the maturation of murine dendritic cells (DCs).

Authors:  Yiming Meng; Qiushi Wang; Zhenjie Zhang; Enhua Wang; Nicollas P Plotnikoff; Fengping Shan
Journal:  Hum Vaccin Immunother       Date:  2013-03-07       Impact factor: 3.452

Review 5.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.

Authors:  Demian van Straten; Vida Mashayekhi; Henriette S de Bruijn; Sabrina Oliveira; Dominic J Robinson
Journal:  Cancers (Basel)       Date:  2017-02-18       Impact factor: 6.639

6.  Photodynamic-therapy Activates Immune Response by disrupting Immunity Homeostasis of Tumor Cells, which Generates Vaccine for Cancer Therapy.

Authors:  Yuanhong Zheng; Guifang Yin; Vanminh Le; Anle Zhang; Siyu Chen; Xin Liang; Jianwen Liu
Journal:  Int J Biol Sci       Date:  2016-01-01       Impact factor: 6.580

7.  Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells.

Authors:  Xiaojie Wang; Jie Ji; Haiyan Zhang; Zhixia Fan; Linglin Zhang; Lei Shi; Feifan Zhou; Wei R Chen; Hongwei Wang; Xiuli Wang
Journal:  Oncotarget       Date:  2015-12-29

8.  Tolerogenic dendritic cell-based immunotherapy.

Authors:  Kiyuk Chang; Jie-Young Song; Dae-Seog Lim
Journal:  Oncotarget       Date:  2017-10-17

Review 9.  Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines.

Authors:  Lien Vandenberk; Jochen Belmans; Matthias Van Woensel; Matteo Riva; Stefaan W Van Gool
Journal:  Front Immunol       Date:  2016-01-14       Impact factor: 7.561

10.  Improvement of DC vaccine with ALA-PDT induced immunogenic apoptotic cells for skin squamous cell carcinoma.

Authors:  Jie Ji; Zhixia Fan; Feifan Zhou; Xiaojie Wang; Lei Shi; Haiyan Zhang; Peiru Wang; Degang Yang; Linglin Zhang; Wei R Chen; Xiuli Wang
Journal:  Oncotarget       Date:  2015-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.